跳至主要内容
临床试验/JPRN-UMIN000042564
JPRN-UMIN000042564已完成未知

Orencia Responsiveness Investigation by Japanese inter-hospital network Study (ORIJIN Study) - ORIJIN Study

Juntendo University School of Medicine, Department of Internal Medicine and Rheumatology0 个研究点目标入组 92 人开始时间: 2020年11月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who violate the following criteria (items 1-5) at the time of eligibility determination before obtaining consent shall be excluded. 1) Patients with a history of hypersensitivity to the ingredients of abatacept preparations 2) Patients with malignant tumor 3) Patients with active infections 4) Hepatitis B and hepatitis B virus carriers (HBsAg positive) 5) Pregnant or lactating patients, or potentially pregnant or lactating patients 6) Patients who are judged by the investigator or investigator to be ineligible for participation in this study

研究者

发起方
Juntendo University School of Medicine, Department of Internal Medicine and Rheumatology

相似试验